Hospitals are not a target.

Please read. 👇
The fact Committee to Protect Journalists has documented fewer journalist deaths in #Gaza in the past few months should not be taken as evidence that the rate has fallen - we cannot say for definite. What we can say for sure is how much harder verification has become. 1/2

We obtained a copy of an African Union audit that examined accusations against Africa CDC's director general. Here's what it found: devex.com/news/exclusive…

At Asia's largest gathering for social investors, leveraging more private sector capital towards climate finance was a leading dilemma. devex.com/news/what-the-…

'Israel is in violation of a White House directive requiring recipients of American military assistance to comply with international humanitarian law and permit the unimpeded delivery of U.S.-funded humanitarian support' devex.com/news/exclusive…

Frank Mugisha is the second most influential African in the world

According to TIME, Frank Mugisha, an LGBT advocate and the Executive Director of Sexual Minorities, hailing from Uganda, is the second-most influential African in the world.

'[Israel’s] refusal to permit foreign journalists independent access to Gaza all speak to a leadership that is deliberately restricting press freedom.”

CPJ's CEO @JodieGinsberg calls for unfettered media access to Gaza in a guest essay for @NYTOpinion:

nytimes.com/2024/04/17/opi…

This week, the UK will likely pass a law saying Rwanda is 'safe' to deport asylum seekers to. Meanwhile, I was recently denied boarding on a flight to Rwanda, presumably because of my journalism on the treatment of refugees there. (THREAD) 1/

Moderna had planned to build an mRNA vaccine manufacturing facility in Kenya. Its decision to put these plans on hold demonstrates the company isn't committed to 'vaccine equity,' Africa CDC said. devex.com/news/africa-cd…

“Africa’s leadership aims to significantly scale up 📈 the amount of pharmaceutical manufacturing happening on the continent.”

Devex’s Sara Jerving explores the challenges in making #IP 🧠 work for #Africanpharma .

⏱️ 18 minute #LongRead

devex.com/news/inside-th…

A wide human capacity gap threatens Africa's genomics goals but efforts to train more scientists are being hindered by brain drain as trained scientists migrate abroad in search of better opportunities. devex.com/news/is-brain-…

There are very few African pharma manufacturers that apply for the Medicines Patent Pool expressions of interest to receive licenses. MPP is considering having Africa-specific calls, which may include offering licenses conditionally. devex.com/news/inside-th…

Devex covers African Pharmaceutical Technology Foundation conference in #Addis reviewing challenges to building a strong #pharmaceutical sector in the region.

Africa’s leadership aims to significantly scale up the amount of pharma manufacturing happening on the continent. Experts gathered for the 1st Intl Conference on Innovation, Intellectual Property and Technology Transfer in Africa’s Pharmaceutical Sector: devex.com/news/inside-th…

Power specifically highlights the portion of Biden’s statement that speaks to systemic failure by Israel to prevent civilian/aid worker casualties.

There is no way to gloss over the concerns this recent event brings to the forefront. And there are some simple ways to reassure the public.

Having spent 25 years in this space, the most critical thing we need to do today is be transparent and timely with all data and…

Alex de Waal has covered famines in Ethiopia, Sudan, Somalia. His prediction on Gaza:

'most intense famine since World War II.'

'Even if the shooting ends today and the aid trucks begin to roll, the dying will carry on for some time'

Grim. Accurate.

theguardian.com/commentisfree/…

Here's the WSJ's front page today

Evan Gershkovich has been a Russian captive for a year. He's a caring friend, a brilliant colleague and an innocent man.

It's beyond time to let him go.

Free Evan.

“Wouldn't it be fantastic if the next time there was a pandemic, the vaccine was produced in Africa?” @Gavi's David Kinder on our African Vaccines Manufacturing Accelerator devex.com/news/high-risk…

.@Gavi, the Vaccine Alliance, is months away from launching a new instrument that will provide up to $1 billion to boost Africa’s vaccine manufacturing sector. I spoke with David Kinder, director of development finance, to learn about how it will work: devex.com/news/high-risk…